Omnipod 5 App2.4.0 - App Store

Omnipod(R) 5 is the only FDA cleared, tubeless automated insulin delivery system that integrates with Dexcom G6 and G7 CGM and automatically adjusts insulin delivery to manage blood glucose with no multiple daily injections and zero fingersticks*.

Simple and automated insulin delivery with the Omnipod 5 System is made possible with the Omnipod 5 Pod, the Omnipod 5 App on an Insulet-provided Controller or on your personal compatible smartphone** and the Dexcom G6 and G7 CGM.

The Omnipod 5 App allows you to select a basal profile, target glucose, deliver a bolus, activate, and deactivate the Pod, connect with the Dexcom G6 and G7 CGM, and more.

* Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings
** For a list of the latest compatible smartphones, please visit: https://www.omnipod.com/compatibility

Intended Use:
The Omnipod 5 App is part of the Omnipod 5 Automated Insulin Delivery System. The Omnipod 5 System is indicated for use by individuals with Type 1 diabetes mellitus in persons 2 years of age and older and for adults with Type 2 diabetes. The Omnipod 5 System is intended for single patient, home use and requires a prescription

The Omnipod 5 System is compatible with the following U-100 insulins: NovoLog(R), Humalog(R), Admelog(R), and Kirsty(R).

Refer to the Omnipod(R) 5 Automated Insulin Delivery System User Guide for complete safety information including indications, contraindications, warnings, cautions, and instructions.

Do not use the Omnipod 5 App without receiving the proper training.
This app store should not be used as your first point of contact to resolve technical or customer services issues. In order to protect your privacy and personal information, and to promptly resolve any technical or customer services issues you are having with any Insulet product, please contact Insulet customer support at 1-800-591-3455 or at Omnipod.com/contact-us.

Disclaimer: You must seek a doctor’s advice in addition to using this app and before making any medical decisions.

(c)2026 Insulet Corporation. Omnipod, Podder, PodderCentral, the Omnipod logo, and Simplify Life are trademarks or registered trademarks of Insulet Corporation. All rights reserved. Dexcom and Dexcom G6 and G7 are registered trademarks of Dexcom, Inc. and used with permission. The use of third-party trademarks does not constitute an endorsement or imply a relationship or other affiliation.
All other trademarks are the property of their respective owners.

Version History Bug fixes & Performance Enhancements 2.4.0 Oct 1 • Introduce a new 100 mg/dL target glucose expanding the current range to 100–150 mg/dL in 10 mg/dL increments
• Automated Delivery Restriction (ADR) no longer requires users to exit Automated Mode, the upper bound constraint notification period has been extended from 1 to 2 hours, permitted system adjustment of insulin delivery when upper bound limit is reached within active safety constraints
• Bug Fixes 2.2.1 Jun 3 • Bug fixes and performance enhancements
• Update to app reauthentication requirements
• Update to the bolus screen to include adjusted for sensor
calculation 2.1.0 12/03/2025 * Performance enhancements and bug fixes 2.0.4 09/15/2025 • Integration with Dexcom G7 CGM 2.0.2 06/10/2025 • Bug fixes and performance enhancements 1.1.6 01/13/2025 Update to allow the Omnipod 5 App to be accessed by a wider age range. 1.1.5 11/07/2024 1.1.4 10/29/2024